UniQure (QURE) Stock Highlights

14.39 | +8.28%

2025-04-23 05:49:15

uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntingtons disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Statistics

Range Today

13.45 14.42

Volume Today 1.71M

Range 1 Year

3.73 19.18

Volume 1 Year 439.96M

Range 3 Year

3.73 28.25

Volume 3 Year 864.55M

Range 10 Year

3.73 82.49

Volume 10 Year 1.61B

Highlights

Market Capitalization 703M (small)

Floating Shares 44.3M

Current Price 14.39

Price To Earnings -2.64

Price To Revenue 30.84

Earnings Per Share -4.92

Payout Ratio 0%

Performance

Latest +8.28%

1 Month +4.81%

3 Months -3.75%

6 Months +116.39%

1 Year +206.17%

3 Years -13.42%

5 Years -75.19%

10 Years -46.51%

Benchmarks

Market Capitalization

193 / 368

Gross Profits

233 / 278

Total Revenue

86 / 300

Total Rank

48 / 368

Free Cashflow

284 / 352

Performance 5 years

203 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.